You searched for "device"
Early vs late activation of cochlear implant device
Device activation after cochlear implant surgery was typically performed after wound healing, and varies anytime from three to four weeks after surgery. Nowadays, activation is performed as early as two to three days after surgery. The authors evaluated the effect...Tinnitus treatment device from concept to commercialisation
Innovation in the field of healthcare is fraught with nearly insurmountable challenges. Bringing a novel product to the market requires a new (patentable) idea that can be reduced to practice, manufactured at scale, and can pass all regulatory barriers. In...
Outcomes at three years post-implantation of the Bonebridge device
This is a MED-EL-funded study of the hearing outcomes and complication rates of the Bonebridge active transcutaneous bone conduction implant (BCI). The authors have declared no conflict of interest. Follow-up occurred at intervals for 36 months post-implantation in all 57...
Surgical anatomy for central auditory device implantation
This cadaveric study by researchers in the USA and Japan examined the cerebellopontine angles with the aid of the surgical microscope and 45o endoscope via the retrosigmoid and translabyrinthine approach. Using fibre dissection technique, the ascending auditory pathways between the...Direct-to-consumer hearing devices: a need to combine cosmetic appeal with device capabilities
How safe and desirable are direct-to-consumer amplification devices? A team has put a range of devices through their paces and compared them to a standard NHS hearing device. Why do most individuals who would benefit from hearing aids not try...Neuromod launches Lenire tinnitus treatment device to tinnitus sufferers in the UK
Neuromod Devices has launched its Lenire tinnitus treatment device in the United Kingdom, where it is estimated that seven million people suffer from tinnitus.Breakthrough tinnitus device Lenire available in three new clinics in Spain
Neuromod has announced that clinically proven tinnitus treatment device, Lenire, is now available in Malaga, Seville and Granada through partnership with medical technology distributor, TRUSBIN.Development of a new negative-pressure ventilatory support device: Exovent
The pandemic has driven innovation in ways that we have not seen for many decades. Intensive care medicine and ENT have been at the forefront of these advances, and our good friends David Howard (never one to put his feet...
Hearing preservation and device benefit following implantation of short or hybrid electrodes
Hybrid or short electrodes have increasingly been used in the literature in order to combine electrical with hearing-aid stimulation. However, hearing preservation of the residual low-frequencies are of utmost importance in this attempt. The present study compared hearing preservation and...
Bone bridge conduction device for patients with bilateral microtia-atresia.
Management of microtia-atresia requires a multidisciplinary approach. Children normally require bone conduction hearing aid devices very early in life to improve and facilitate speech and language development. At a later stage, when the cranial bones have strengthened and become thicker,...FDA grants Lenire tinnitus treatment device De Novo approval
Neuromod Devices Ltd. is proud to announce that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire.
